A central pathological mechanism explaining diabetic complications?;Un mécanisme physiopathologique central à l'origine des complications du diabète?

Revue Medicale de Liege

Volumn 60, Issue 5-6, 2005, Pages 472-478

  Defraigne, J O ^a,b  

^a CHU SART TILMAN   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Diabetic complications; Hyperglycaemia; Mitochondria; Oxidative stress

Indexed keywords

HEXOSAMINE; POLYOL; PROTEIN KINASE C;

DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; GLYCATION; HEART INFARCTION; HYPERGLYCEMIA; MEMBRANE TRANSPORT; METABOLIC DISORDER; MITOCHONDRION; OXIDATIVE STRESS; REVIEW;

BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS; ENZYME ACTIVATION; FREE RADICALS; HEXOSAMINES; HUMANS; HYPERGLYCEMIA; MITOCHONDRIA; POLYMERS; PROTEIN KINASE C;

EID: 21744444628     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Brownlee M.- Biochemistry and molecular cell biology of diabetic complications. Nature, 2001, 414, 813-820.
2. Lee AY, Chung SS.- Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J, 1999, 13, 23-30
3. Degenhardt TP, Thorpe SR, Baynes JW.- Chemical modification of proteins by methylglyoxal? Cell Mol Biol, 1998, 44, 1139-1145.
4. Tanaka S, Avigad G, Brodsky B, Eikenberry EF.- Glycation induces expansion of the molecular packing of collagen. J Mol Biol, 1988, 203, 495-505.
5. Federoff HJ, Lawrence D, Brownlee M.- Non enzymatic glycosylation of laminin and the laminin peptide CIK-VAVS inhibits neurite outgrowth. Diabetes, 1993, 42, 509-513.
6. Yemeni KK, Bai W, Khan BV, et al.- Hyperglycemia-induced activation of nuclear factor kappaB in vascular smooth muscle cells. Diabetes, 1999, 48, 855-864.
7. Kirstein M, Aston C, Hintz R, Vlassara H.- Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. J Clin Invest, 1992, 90, 439-446.
8. Craven PA, Studer RK, DeRubertis FR.- Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated. J Clin Invest, 1994, 93, 311-320.
9. Glogowski EA, Tsiani E, Zhou X, et al.- High glucose alters the response of mesangial cell protein kinase C isoforms to endothelin-1. Kidney Int, 1999, 55, 486-499.
10. Kolm-Litty V, Sauer U, Nerlich A, et al.- High-glucose induced transforming growth factor β1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cell. J Clin Invest, 1998, 101, 160-169.
11. Marshall S, Bacote V, Traxinger RR.- Discovery of a metabolic pathway mediating glucose-induced desentization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem, 1991, 266, 4706-4712.
12. Giugliano D, Ceriello A, Paolisso G.- Oxidative stress and diabetic vascular complications. Diabetes Care, 1996, 19, 257-267.
13. Brownlee M.- A radical explanation for glucose-induced β cell dysfunction. J Clin Invest, 2003, 112, 1788-1790.
14. Khorshunov SS, Skulachev VP, Starkov AA.- High protonic potential actuates a mechanism of production of reactive species in mitochondria. FEBS Lett, 1997, 416, 15-18.
15. Giardino I, Edelstein D, Brownlee M.- BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest, 1996, 97, 1422-1428.
16. 2+ superoxyde dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes, 2001, 50, 2114-2125.
17. Quinn M, Angelico MC, Warram JH, Krolewski AS.- Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia, 1996, 39, 940-945.
18. The Diabetes Control and Complications Trial Research Group.- Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes, 1997, 46, 1829-1839.
19. Heart Outcomes Prevention Evaluation Study Investigators.- Effect of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudy. Lancet, 2000, 355, 253-259.